共 60 条
[11]
Lakka TA(2001)Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) BMJ 322 15-18
[12]
Coutinho M(2002)Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease Diabetologia 45 461-475
[13]
Gerstein HC(2000)Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 145-153
[14]
Wang Y(1996)Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE study Diabetes Care 19 1225-1228
[15]
Yusuf S(2000)Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 355 253-259
[16]
Gerstein HC(1996)The HOPE (Heart Outcomes Prevention Evaluations) Study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events Can J Cardiol 12 127-137
[17]
Anand S(2003)Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study J Am Soc Nephrol 14 641-647
[18]
Yi QL(1999)Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 341-353
[19]
Stratton IM(2004)Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 421-431
[20]
Adler AI(2002)Dysglycemia: a key cardiovascular risk factor Semin Vasc Med 2 165-174